Emerging treatment strategies for COVID-19 infection-Reference-Cited by-同舟云学术

Emerging treatment strategies for COVID-19 infection

Published:2020-10-30 Issue:2 Volume:21 Page:167-179
ISSN:1591-8890
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Gavriatopoulou Maria^ORCID,Ntanasis-Stathopoulos Ioannis,Korompoki Eleni,Fotiou Despina,Migkou Magdalini,Tzanninis Ioannis-Georgios,Psaltopoulou Theodora,Kastritis Efstathios,Terpos Evangelos,Dimopoulos Meletios A.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-020-00671-y.pdf

Reference106 articles.

1. Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–6.

2. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787–99.

3. Tiberghien P, de Lambalerie X, Morel P, et al. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how. Vox Sang. 2020;115(6):488–94.

4. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130:1545–8.

5. Bloch EM, Shoham S, Casadevall A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020;30:2757–65.

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An In-Depth Exploration of Snake Venom-Derived Molecules for Drug Discovery in Advancing Antiviral Therapeutics;Heliyon;2024-09

2. From a validated targeted method to a retrospective UHPLC-HRMS non-targeted analysis unveiling COVID-19-related contaminants in clams. Have we bias in marine model organisms for ecotoxicological studies?;Chemosphere;2024-09

3. A Retrospective Study: Evaluating the Impact of the COVID-19 Pandemic on Inflammatory Markers in Hospitalized Patients;Infectious Disease Reports;2024-08-14

4. The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity;Frontiers in Pharmacology;2024-08-01

5. Identifying Key Clinical Indicators Associated with the Risk of Death in Hospitalized COVID-19 Patients;Current Bioinformatics;2024-08-01